Nirvana Life Sciences Inc. announce further progress with development of its Vancouver research and development facility. The Company has taken delivery of key pieces of equipment required to support the research and development facility. This equipment package valued at $800,000.00 includes a state-of-the-art Distillation apparatus that will be key to research, development and eventual production of controlled substances for therapeutic uses, novel compounds and analysis.

The distillation apparatus, that includes an exclusive license for the psychedelic sector, will be instrumental in keeping the Company at the leading edge in development of a number of compounds, as well as offering a high level of transparency for regulators, due to the unit's data collection abilities. Also in the package are two chromatography units; the first a quad-pole LC-MS (Liquid chromatography mass spectrometer) that will be fundamental in detecting and identifying high purity compounds and precursors. And the second, a chromatography pump that will be used for isolating pristine compounds within a complex mixture, giving the ability to rapidly develop API's. This equipment will remain in storage pending licensing of the research facility.